ReviewCancer drug resistance (Alhambra, Calif.)2023

Targeting BCL2 pathways in CLL: a story of resistance and ingenuity.

Amanda Reyes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.